Jonathan Sheena - 13 Nov 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Nov 2024, 21:05:08 UTC
Prior SEC filing
12 Nov 2024
Next SEC filing
20 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tami Chen, Attorney-in-Fact
Filing notes and source

Key filing fact

Jonathan Sheena filed Form 4 for Natera, Inc. (NTRA) on 15 Nov 2024.

Key facts

  • This page summarizes Jonathan Sheena's Form 4 filing for Natera, Inc. (NTRA).
  • 8 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 15 Nov 2024, 21:05.

Change

  • Previous filing in this sequence was filed on 12 Nov 2024.
  • Current net transaction value: -$5,621,396.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Sale

Transaction value
$1,225,472
Shares
-8,026
Change %
-2.9%
Price
$152.69
Shares after
271,746
Date
13 Nov 2024
Ownership
Direct
Footnotes
F1, F2
NTRA transaction

Common Stock

Sale

Transaction value
$1,845,296
Shares
-11,974
Change %
-4.4%
Price
$154.11
Shares after
259,772
Date
13 Nov 2024
Ownership
Direct
Footnotes
F1, F3
NTRA transaction

Common Stock

Sale

Transaction value
$612,806
Shares
-4,011
Change %
-7.2%
Price
$152.78
Shares after
51,921
Date
13 Nov 2024
Ownership
By Caraluna 1 Trust
Footnotes
F4, F5, F6
NTRA transaction

Common Stock

Sale

Transaction value
$9,825
Shares
-64
Change %
-0.12%
Price
$153.51
Shares after
51,857
Date
13 Nov 2024
Ownership
By Caraluna 1 Trust
Footnotes
F4, F6
NTRA transaction

Common Stock

Sale

Transaction value
$652,083
Shares
-4,075
Change %
-7.9%
Price
$160.02
Shares after
47,782
Date
13 Nov 2024
Ownership
By Caraluna 1 Trust
Footnotes
F4, F6, F7
NTRA transaction

Common Stock

Sale

Transaction value
$553,134
Shares
-3,617
Change %
-6.5%
Price
$152.93
Shares after
52,315
Date
13 Nov 2024
Ownership
By Caraluna 2 Trust
Footnotes
F4, F6, F8
NTRA transaction

Common Stock

Sale

Transaction value
$70,715
Shares
-458
Change %
-0.88%
Price
$154.40
Shares after
51,857
Date
13 Nov 2024
Ownership
By Caraluna 2 Trust
Footnotes
F4, F6, F9
NTRA transaction

Common Stock

Sale

Transaction value
$652,065
Shares
-4,075
Change %
-7.9%
Price
$160.02
Shares after
47,782
Date
13 Nov 2024
Ownership
By Caraluna 2 Trust
Footnotes
F4, F6, F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 10 footnotes

Footnote F1

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.50 to $153.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.8950 to $154.6300 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.

Footnote F5

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.50 to $153.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

Footnote F7

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.0000 to $160.0850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F8

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.50 to $153.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F9

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.0650 to $154.63000 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F10

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.00 to $160.04 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .